Drug Type CAR-T |
Synonyms dPD-1 (TSHR+CD19) CART cells, ICTCAR023 |
Target |
Mechanism CD19 inhibitors(B-lymphocyte antigen CD19 inhibitors), TSHR modulators(Thyroid stimulating hormone receptor modulators) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 1/2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Thyroid Cancer | Phase 2 | CN | 18 Sep 2019 |